Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.080
-0.020 (-1.82%)
At close: Jun 29, 2026, 4:00 PM EDT
1.060
-0.020 (-1.85%)
After-hours: Jun 29, 2026, 7:24 PM EDT
Immuron Market Cap
Immuron has a market cap or net worth of $7.87 million as of June 29, 2026. Its market cap has decreased by -22.11% in one year.
Market Cap
7.87M
Enterprise Value
1.13M
1-Year Change
-22.11%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $7.87M, a decrease of -72.00%. That is a compound annual growth rate of -13.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 9.00M | 100.00% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaCyte Biotech | 8.26M |
| Bolt Biotherapeutics | 8.21M |
| Ernexa Therapeutics | 8.13M |
| Aspire Biopharma Holdings | 7.77M |
| Curanex Pharmaceuticals | 7.53M |
| Imunon | 7.52M |
| Kairos Pharma | 7.49M |
| MetaVia | 7.39M |